Literature DB >> 12162765

Functional outcomes after treatment of squamous cell carcinoma of the base of the tongue.

Mark A Perlmutter1, Jonas T Johnson, Carl H Snyderman, Elmer R Cano, Eugene N Myers.   

Abstract

OBJECTIVE: To compare functional outcome and quality of life after various treatments for squamous cell carcinoma of the base of the tongue.
DESIGN: Retrospective survey using statistical comparison.
SETTING: Academic medical center, institutional practice. PARTICIPANTS: Patients treated for squamous cell carcinoma of the base of the tongue between 1976 and 2000. Living patients 3 or more months after treatment were eligible. Questionnaire packets including validated site-specific quality-of-life instruments were mailed to 105 qualifying patients. Sixty-one patients participated, forming a volunteer sample. Patient responses were grouped according to treatment modality, operative vs nonoperative. MAIN OUTCOME MEASURES: The planned outcome was that nonoperative therapy would result in better function than operative treatment.
RESULTS: Most comparisons indicated no statistical difference in outcome between operative and nonoperative groups. Significant differences (95% confidence interval) were calculated for age, interval since treatment, and T stage. Group comparisons of patient responses revealed significant differences only in xerostomia and days hospitalized.
CONCLUSIONS: The tongue remains dysfunctional after both surgical and nonoperative treatment. Nonoperative treatment might more adversely affect saliva. Surgery is associated with a longer hospital stay.

Entities:  

Mesh:

Year:  2002        PMID: 12162765     DOI: 10.1001/archotol.128.8.887

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  9 in total

1.  Optical imaging predicts tumor response to anti-EGFR therapy.

Authors:  Emily E Helman; J Robert Newman; Nichole R Dean; Wenyue Zhang; Kurt R Zinn; Eben L Rosenthal
Journal:  Cancer Biol Ther       Date:  2010-07-15       Impact factor: 4.742

Review 2.  Speech and swallowing after surgical treatment of advanced oral and oropharyngeal carcinoma: a systematic review of the literature.

Authors:  Anne Marijn Kreeft; Lisette van der Molen; Frans J Hilgers; Alfons J Balm
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11       Impact factor: 2.503

Review 3.  A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.

Authors:  S B Jensen; A M L Pedersen; A Vissink; E Andersen; C G Brown; A N Davies; J Dutilh; J S Fulton; L Jankovic; N N F Lopes; A L S Mello; L V Muniz; C A Murdoch-Kinch; R G Nair; J J Napeñas; A Nogueira-Rodrigues; D Saunders; B Stirling; I von Bültzingslöwen; D S Weikel; L S Elting; F K L Spijkervet; M T Brennan
Journal:  Support Care Cancer       Date:  2010-03-17       Impact factor: 3.603

4.  Sociodemographic risk indicators for depressive symptoms among persons with oral cancer or oral epithelial dysplasia.

Authors:  Susan Reisine; Douglas E Morse; Walter J Psoter; Ellen Eisenberg; Donald Cohen; Deborah Cleveland; Mirseyed Mohit-Tabatabai
Journal:  J Oral Maxillofac Surg       Date:  2005-04       Impact factor: 1.895

5.  Long-term oral effects in patients treated with radiochemotherapy for head and neck cancer.

Authors:  Aline Lima da Silva Deboni; Adelmo José Giordani; Nilza Nelly Fontana Lopes; Rodrigo Souza Dias; Roberto Araujo Segreto; Siri Beier Jensen; Helena Regina Comodo Segreto
Journal:  Support Care Cancer       Date:  2012-03-13       Impact factor: 3.603

6.  Functional results of speech and swallowing after oral microvascular free flap reconstruction.

Authors:  Maria Archontaki; Athanasios Athanasiou; Spyros D Stavrianos; Dimitris P Korkolis; Gregory Faratzis; Flora Papadopoulou; Georgios Kokkalis; Alexander D Rapidis
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-21       Impact factor: 2.503

7.  A comparison of the reliability and stability of oro-lingual swallowing pressures in patients with head and neck cancer and healthy adults.

Authors:  Ruth White; Susan M Cotton; Jackie Hind; JoAnne Robbins; Alison Perry
Journal:  Dysphagia       Date:  2008-10-28       Impact factor: 3.438

8.  Bioactive phytochemical proanthocyanidins inhibit growth of head and neck squamous cell carcinoma cells by targeting multiple signaling molecules.

Authors:  Ram Prasad; Santosh K Katiyar
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

9.  Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.

Authors:  Tripti Singh; Nirzari A Gupta; Su Xu; Ram Prasad; Sadanandan E Velu; Santosh K Katiyar
Journal:  Oncotarget       Date:  2015-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.